The US Food and Drug Administration has approved a number of clinical trials to to test blood plasma therapy in COVID-19 patients.
Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start
Plus: Japan Accelerates Research As Outbreak Worsens
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.
